Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.84
+0.32 (5.80%)
At close: Nov 13, 2026, 4:00 PM EST
5.84
0.00 (0.00%)
After-hours: Nov 13, 2026, 4:15 PM EST
Cytek Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 66.81 | 90.85 | 98.72 | 167.3 | 296.6 | 364.62 |
Short-Term Investments | 189.09 | 170.68 | 179.15 | 95.11 | 44.55 | - |
Cash & Short-Term Investments | 255.9 | 261.53 | 277.86 | 262.41 | 341.15 | 364.62 |
Cash Growth | -2.23% | -5.88% | 5.89% | -23.08% | -6.44% | 120.67% |
Accounts Receivable | 59.19 | 62.51 | 60.59 | 55.93 | 48.86 | 29.76 |
Other Receivables | 1.59 | 9.62 | - | 0.19 | 2.01 | -0.13 |
Receivables | 60.78 | 72.13 | 60.59 | 56.12 | 50.88 | 29.63 |
Inventory | 53.47 | 48.66 | 44.01 | 61.17 | 48.78 | 32.57 |
Prepaid Expenses | 2.91 | 6.9 | 6.58 | 3.99 | 4.45 | 4.21 |
Restricted Cash | 0.39 | - | 0.03 | 0.33 | 2.9 | - |
Other Current Assets | 5.49 | 2.79 | 7.38 | 8.04 | 5.88 | 0.71 |
Total Current Assets | 378.94 | 392 | 396.45 | 392.06 | 454.02 | 431.73 |
Property, Plant & Equipment | 30.94 | 29.32 | 28.13 | 29.26 | 27.57 | 5.85 |
Long-Term Investments | - | 1.6 | - | - | - | - |
Goodwill | 16.69 | 16.7 | 16.66 | 16.18 | 10.14 | 10.14 |
Other Intangible Assets | 14.03 | 16.82 | 20.13 | 23.08 | 4.33 | 4.74 |
Long-Term Deferred Tax Assets | - | - | 33.37 | 30.49 | 20.46 | 9.17 |
Other Long-Term Assets | 5.55 | 5.1 | 4.76 | 3.39 | 2.96 | 1.67 |
Total Assets | 446.15 | 461.54 | 499.5 | 494.46 | 519.48 | 463.31 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4.89 | 6.41 | 5.53 | 3.03 | 4.81 | 3.03 |
Accrued Expenses | 29.42 | 25.18 | 21.69 | 18.99 | 20.42 | 14.89 |
Short-Term Debt | 7.75 | 5.7 | - | - | - | - |
Current Portion of Long-Term Debt | 0.6 | 0.6 | 4.66 | 0.57 | 0.58 | - |
Current Portion of Leases | 3.46 | 2.88 | 3.76 | 2.44 | 2.93 | - |
Current Income Taxes Payable | 2.56 | 3.07 | 1.52 | 1.3 | 0.25 | 2.48 |
Current Unearned Revenue | 32.07 | 29.57 | 26.61 | 24.13 | 14.54 | 8.1 |
Other Current Liabilities | 4.2 | 4.4 | 3.9 | 5.76 | 5.52 | 4.68 |
Total Current Liabilities | 84.95 | 77.8 | 67.66 | 56.23 | 49.04 | 33.18 |
Long-Term Debt | 0.1 | 0.53 | 1.05 | 1.65 | 2.27 | - |
Long-Term Leases | 12.78 | 14.04 | 7.55 | 9.48 | 12.31 | - |
Long-Term Unearned Revenue | 18.74 | 18.34 | 16.1 | 15.13 | 13.12 | 9.79 |
Other Long-Term Liabilities | 8.22 | 9.09 | 11.4 | 18.91 | 17.18 | 14.95 |
Total Liabilities | 124.79 | 119.8 | 103.76 | 101.39 | 93.93 | 57.92 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.13 | 0.13 | 0.13 | 0.13 | 0.14 | 0.13 |
Additional Paid-In Capital | 457.44 | 441.11 | 430.79 | 423.39 | 442.89 | 423.63 |
Retained Earnings | -138.86 | -101.74 | -35.2 | -29.18 | -17.03 | -19.61 |
Comprehensive Income & Other | 2.64 | 2.24 | 0.02 | -1.28 | -0.7 | 0.9 |
Total Common Equity | 321.35 | 341.74 | 395.74 | 393.06 | 425.3 | 405.04 |
Minority Interest | - | - | - | - | 0.25 | 0.34 |
Shareholders' Equity | 321.35 | 341.74 | 395.74 | 393.06 | 425.55 | 405.39 |
Total Liabilities & Equity | 446.15 | 461.54 | 499.5 | 494.46 | 519.48 | 463.31 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 24.69 | 23.74 | 17.02 | 14.14 | 18.09 | - |
Net Cash (Debt) | 231.21 | 237.79 | 260.85 | 248.27 | 323.06 | 364.62 |
Net Cash Growth | -2.40% | -8.84% | 5.06% | -23.15% | -11.40% | 124.44% |
Net Cash Per Share | 1.79 | 1.86 | 2.00 | 1.84 | 2.33 | 4.47 |
Filing Date Shares Outstanding | 130.78 | 128.55 | 128.1 | 130.82 | 135.43 | 134.08 |
Total Common Shares Outstanding | 130.77 | 128.55 | 129.21 | 130.71 | 135.37 | 133.75 |
Working Capital | 293.98 | 314.19 | 328.78 | 335.83 | 404.98 | 398.55 |
Book Value Per Share | 2.46 | 2.66 | 3.06 | 3.01 | 3.14 | 3.03 |
Tangible Book Value | 290.64 | 308.22 | 358.95 | 353.8 | 410.82 | 390.16 |
Tangible Book Value Per Share | 2.22 | 2.40 | 2.78 | 2.71 | 3.03 | 2.92 |
Buildings | 8.26 | 7.92 | 7.76 | 7.65 | 5.55 | - |
Machinery | 19.42 | 17.29 | 15.33 | 12.79 | 7.63 | 4.35 |
Construction In Progress | 0.75 | 1.42 | 0.36 | 0.26 | 0.18 | 0.34 |
Leasehold Improvements | 7.56 | 3.52 | 3.22 | 3.62 | 3.48 | 3.02 |